Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene
Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Celgene Corporation
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
Bristol-Myers Squibb Completes Acquisition of Celgene
Upon completion of the acquisition, pursuant to the terms of the merger agreement, Celgene became a wholly owned subsidiary of…